Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Standard outcome measures for thymic malignancies.

James Huang1, Frank C Detterbeck, Zuoheng Wang

  • 1Division of Thoracic Surgery, Department of Surgery, Yale University School of Medicine, Yale University, New Haven, Connecticut, USA.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|October 28, 2010
PubMed
Summary

Standardized reporting of outcomes for thymic malignancies is crucial due to disease complexity. The International Thymic Malignancy Interest Group established reporting standards to improve data comparability and clinical study interpretation.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Future Considerations When Considering Partial Thymectomy.

The Annals of thoracic surgery·2026
Same author

Less May Be Enough: Clinical Equipoise for Partial Thymectomy.

The Annals of thoracic surgery·2026
Same author

Natural History, Treatment, Survival, and Causes of Mortality in Patients With Subsolid and Ground-Glass Nodules.

Chest·2026
Same author

Comparison of Oncologic Outcomes After Partial and Total Thymectomy for Stage I Thymomas.

The Annals of thoracic surgery·2025
Same author

Development and Validation of a Machine Learning-Based Screening Algorithm to Predict High-Risk Hepatitis C Infection.

Open forum infectious diseases·2025
Same author

Short- and long-term outcomes of chest wall resection and reconstruction for breast cancer.

The Journal of thoracic and cardiovascular surgery·2025

Area of Science:

  • Oncology
  • Clinical Research Methodology

Background:

  • Thymic malignancies pose unique challenges in clinical research due to rapid progression, recurrence patterns, and mortality.
  • Limited patient populations in thymic malignancy studies risk over-interpretation and misleading conclusions.
  • Consistent outcome reporting is essential for accurate interpretation of clinical experiences.

Purpose of the Study:

  • To establish standardized outcome reporting measures for clinical studies on thymic malignancies.
  • To facilitate comparison of results across different research series and institutions.
  • To enhance the collective understanding and management of thymic cancers.

Main Methods:

  • Development of a consensus-based set of standards for outcome reporting.
  • Adoption of these standards for collaborative projects within the International Thymic Malignancy Interest Group.

Related Experiment Videos

  • Guidelines focus on key metrics relevant to disease progression, recurrence, and survival.

    • Main Results:

    • A standardized framework for reporting outcomes in thymic malignancy studies has been developed and adopted.
    • The established standards aim to improve data consistency and reduce variability in study results.
    • Implementation of these standards is expected to enhance the reliability of findings from collaborative research.

    Conclusions:

    • Standardized outcome reporting is vital for advancing the study of thymic malignancies.
    • Widespread adoption of these baseline standards will enable more robust comparisons between clinical studies.
    • This initiative by the International Thymic Malignancy Interest Group will improve the quality and comparability of evidence in thymic oncology.